A Look At Immunocore (IMCR) Valuation After Jefferies Downgrade And Kimmtrak Growth Concerns [Yahoo! Finance]
Immunocore Holdings plc - American Depositary Shares (IMCR)
Company Research
Source: Yahoo! Finance
Immunocore Holdings (IMCR) came under renewed scrutiny after Jefferies cut its rating to Hold on March 16, 2026, citing concerns about Kimmtrak approaching peak sales and uncertainty around the broader pipeline. See our latest analysis for Immunocore Holdings. The downgrade has landed after a weak run for the shares, with a 30 day share price return of 8.46% and a 90 day share price return of 18.52% decline. The 1 year total shareholder return of 0.47% loss contrasts with a much steeper 3 year total shareholder return of 40.45% loss, suggesting momentum has been fading as investors reassess the risks around Kimmtrak and the wider clinical pipeline. If this kind of stock specific volatility has you looking at the broader healthcare and biotech space, it could be a useful time to scan for other clinical stage names using our curated list of healthcare focused AI opportunities via 34 healthcare AI stocks With Immunocore now valued at about US$1.5b and trading well below the aver
Show less
Read more
Impact Snapshot
Event Time:
IMCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMCR alerts
High impacting Immunocore Holdings plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMCR
News
- Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive OfficerGlobeNewswire
- Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting [Yahoo! Finance]Yahoo! Finance
- Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meetingGlobeNewswire
- Immunocore (IMCR) was downgraded by Jefferies Financial Group Inc. from "buy" to "hold". They now have a $33.00 price target on the stock.MarketBeat
IMCR
Earnings
- 2/25/26 - Miss
IMCR
Sec Filings
- 3/11/26 - Form 144
- 3/6/26 - Form SCHEDULE
- 2/25/26 - Form 8-K
- IMCR's page on the SEC website